New drug hope for blood cancers

A new pill launched in the UK has the potential to transform the treatment of blood cancers, it is claimed. Currently ibrutinib, marketed as Imbruvica, can be given to patients with chronic lymphocytic leukaemia or refractory mantle cell lymphoma .

Newspaper skewers Paul over vaccinations

Sen. Rand Paul may be blaming the “liberal media” for the recent controversy over his comments about vaccinations, but the right-leaning editorial board of the Wall Street Journal published a blistering opinion piece published in Wednesday’s edition...